Kairos Pharma Ltd.

KAPA | AMEX

Price Alert Chart Builder DCF Calculator

$1.75

+$0.02 (+1.16%)

At close: Sep 21, 2026, 3:59 PM ET

$1.75

$0 (0.00%)

After-hours: Sep 21, 2026, 6:25 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.48M

Enterprise Value $2.73M

Beta 1.48

Average Volume 253.68K

Shares Outstanding (Diluted) 3.06M

Shares Change YoY 24.44%

Institutional Ownership 2.86%

Exchange AMEX

ISIN US48301N2036

Price Performance

Price Change 1M 12.2%

Price Change 3M -41.5%

Price Change 6M -58.4%

Price Change YTD -65.7%

Price Change 1Y -78.3%

Price Change 3Y -88.6%

Price Change 5Y -88.6%

1M CAGR (ann.) -33.7%

1Y CAGR (ann.) -80.9%

5Y CAGR (ann.) N/A

All-Time CAGR -68.4%

Valuation

PE Ratio -0.90

Forward PE N/A

PEG Ratio -0.05

Forward PEG -0.02

PS Ratio N/A

Forward PS N/A

PB Ratio 1.28

P/FCF Ratio -1.35

P/Adj. FCF Ratio -1.27

P/OCF Ratio -1.35

EV/Sales N/A

EV/EBIT -0.47

EV/EBITDA -0.48

EV/FCF -0.69

Earnings Yield -110.9%

FCF Yield -74.2%

Adj. FCF Yield -79.0%

Financial Health

Net Cash $2.63M

Total Debt $0

Cash & Short-Term Investments $2.63M

Total Assets $4.46M

Current Ratio 11.98

Quick Ratio 11.98

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 3.44

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.5%

Returns

Return on Assets -130.3%

Return on Equity -98.8%

Return on Invested Capital -143.9%

Return on Capital Employed -143.9%

Return on Tangible Assets -130.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -16.7%

EPS CAGR 5Y -20.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -64.5%

FCF CAGR 5Y -59.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y -11.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.56

EPS Growth Est (next Q) 14.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside 414.3%

Cash Flow

Operating Cash Flow $-3.97M

Free Cash Flow $-3.97M

Adj. Free Cash Flow $-4.23M

FCF Per Share -$1.30

OCF Per Share -$1.30

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $80K

Operating Income $-6.03M

EBITDA $-5.66M

Net Income $-5.81M

EPS (Diluted) -$1.94

Revenue / Employee N/A

Profit / Employee $-1.45M

Employees 4